• Medicus Pharma regained compliance with Nasdaq's $1 minimum bid price requirement on October 23, 2026, closing the matter.
• Shares closed at $1 or higher for 10 consecutive business days from October 12 through October 23, 2026.
• The compliance notice superseded Nasdaq's October 20, 2026, determination to delist the company's common shares and warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005528), on October 23, 2026, and is solely responsible for the information contained therein.